Short sellers turned aggressive this week. Wolfspeed sits at 87% SI of free float, up 7.6 percentage points in just seven days. The chip maker's shares have shed 41% over three months. Bears see no floor yet. Borrow availability has hit zero — a sign shorts are fully committed.
Replimune had the biggest weekly jump among mid-caps. SI % of FF leapt from 26% to 38% in a week — a near-12-point surge. The biotech has a cost to borrow near zero, meaning shorts face little friction.
Galectin Therapeutics holds an 89 short score. SI sits at 69% of free float. Cost to borrow is 14%. Despite a 60% price gain in three months, bears are not backing down.
Hertz carries 64% SI % FF with zero borrow availability. The CTB is 11%. That combination makes a squeeze technically possible — but thin availability keeps fresh shorts locked in.
On the other side, Chewy saw shorts retreat sharply. SI dropped nearly 12 points to 65%. With a massive borrow availability of 523%, covering is easy. The pet retailer may be finding favour again.
Asana also saw shorts exit, SI falling from 39% to 31% in a week. Both moves suggest tactical covering rather than a conviction shift.
Bond markets and macro jitters dominate headlines, but the real action for short sellers is squarely in beaten-down biotech and distressed industrials.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
